Figure 1
From: A unique peptide deformylase platform to rationally design and challenge novel active compounds
Chemical structures of PDF inhibitors.
(a) compounds synthesized in previous studies. (b,c) new compounds of the oxadiazole series with either an n-butyl (b) or a cyclopentyl (c) at P1’. (d) new compounds of the oxazole series.
